The research group is an interdisciplinary forum that perform clinical trials and translational research on pancreatic cancer and pancreatic cysts. The research group studies the importance of environmental and genetic factors in cancer development, prognostic and predictive factors, early diagnosis, and the efficacy of surgical- oncological- and symptomatic treatment. Patients with pancreatic tumors treated at Oslo University Hospital is requested consent for storage of biological material and clinical data for use in research. The research group has established a clinical data registry and a biobank with an associated database. This ensures a systematic, prospective registration of patients with pancreatic cancer who are being treated at the hospital. Clinical registry contains relevant clinical and histopathological data from routine diagnostics. Biobank database contains the results of clinical and molecular research.

Ongoing projects:

• Thematic Pancreatic Tumour Project
• Norwegian Pancreatic Cancer Trials 1 and 2 (NORPACT)
• DIPLOMA Trial

Planned research:

The research group performs clinicaland molecular studies on pancreatic cancer and pancreatic cysts to improve the knowledge about pancreatic cancer and the development of pancreatic cancer, in order to improve the diagnosis, treatment and prognosis for patients with pancreatic cancer. The main goal is to initiate and perform clinical trials with bolt on translational research aimed at determining the overall benefits of current treatments and evaluating the benefits of newly emerging treatments for pancreatic cancer.